Author: acn

香港, 2025年1月6日 - (亚太商讯 via SeaPRwire.com) - 泛远国际控股集团有限公司（上市编号：2516，下称'泛远国际'；连同其附属公司，统称'泛远国际'或'本集团'）欣然宣布，本集团间接全资附属公司Ingrun Holdings Limited（'Ingrun'）于2025年1月3日交易时段后以现金代价635,318.4美元（约493万港元*）收购美国物流公司Advanced Logistics Solutions LLC（'Advanced Logistics'）之30%股权。此次收购有助提升本集团在美国乃至海外物流网络的竞争力，为布局全球市场奠定坚实基础。根据收购协议，Ingrun向Hi5s, LLC（美国犹他州成立的有限公司）及Hard 8, LLC（美国佛罗里达州成立的有限公司）分别收购其各自持有Advanced Logistics之15%公司股权，现金代价合共为635,318.4美元（约493万港元*），将以本集团的内部资源拨付。于交割完成后，本集团之间接全资附属公司Ingrun将持有Advanced Logistics合共30%之股权，并将其视作为本集团之联营公司。早于权益收购前， Advanced Logistics已是本集团在美国的供应商，其经营集装箱货运站并于包裹运抵美国机场后为本集团提供揽收、分拣及仓库及清关服务，近年双方往来交易亦屡创新高，交易规模由1,000万元人民币逐年递增至6,000万元人民币，伙伴关系紧密稳固。收购Advanced Logistics部分股权是本集团深入海外市场版图，尤其是美国市场、提升海外物流网络供应链的透明度和成本效益的重要举措。Advanced Logistics在Type 86（T86）清关和集装箱货运站（CFS）仓储服务上具备显著优势，包括其在美国拥有丰富T86清关经验及专业团队，经收购后能为本集团提供高效、顺畅的跨境电商清关流程，减少通关时间及成本，确保包裹顺利进入美国市场；Advanced Logistics亦在美国主要港口设有CFS仓库，其不仅承担着自接收、分拣到配送运输等重要物流功能，亦能作为海关监管仓库实现更精确的货物监控和合规性审查，此等核心优势能完善本集团于美国的物流网络供应链，为跨境电商包裹提供高效完善的管理及整合服务，更大大降低潜在的清关风险，有效提升整体物流供应链的透明度和控制力。本集团作为知名的跨境电子商务物流服务供应商，提供端到端物流服务及国际货运代理等服务，经营中美、南美等多条专线，同时拥有在美国七大口岸的操作能力。本次收购Advanced Logistics部分权益旨在加强于美国市场的物流供应链布局，以把握美国物流市场的发展机遇。根据美国供应链管理专业协会2024年11月最新发布的LMI指数（物流经理人指数）是58.9，为两年来的最高水平，总体指数亦实现连续十一个月上升，反映美国市场需求上升，物流行业正重回稳固水平，市场蕴藏机遇，而规模化及高效的物流网络更有望从中突围而出。是次股权收购为本集团在美跨境物流业务的拓展提供优厚条件，展现集团扩展跨境电商物流业务版图的决心，亦有助于加快融入目标地区市场，增加市场份额及业务营收。泛远国际控股集团有限公司主席、行政总裁兼执行董事王泉先生表示：'年内集团频传佳音，此次收购Advanced Logistics部分权益是继泛远国际接连获颁'4A级物流企业'及'大湾区新质生产力企业大奖 - 运输，货运，物流及供应链奖'后又一利好消息。这一举措不仅增强我们的市场竞争力，也进一步完善海外业务部署，极大提高服务能力。我们将与Advanced Logistics优势互补、高度协同，共同为集团在美国业务的开发与拓展努力。我们相信，此次收购将为股东和投资者带来诸多裨益，可望创造更大价值。'*按概约汇率1.0美元兑7.76港元换算有关泛远国际控股集团有限公司（股份代号：2516.HK）泛远国际控股集团有限公司于2023年12月在香港联交所主板挂牌上市，为中国知名的跨境电子商务物流服务供应商，主要提供端到端跨境配送服务、货运代理服务以及其他物流服务，致力打造稳、快、优的跨境电子商务物流服务体系。本集团作为中国（杭州）跨境电子商务综合试验区首批试点企业，拥有创新的自研物流运输系统，采用直营网点模式，网点遍布中国主要贸易中心，尤其聚焦于长江三角洲及粤港澳大湾区。本集团设有30多个境内网点，1,100多家供应商网络，服务覆盖全球超过220多个国家和地区，向客户提供多项灵活可靠的跨境配送选项及定制化供应链解决方案。 Copyright 2025 亚太商讯 via SeaPRwire.com.

SINGAPORE, Jan 2, 2025 - (ACN Newswire via SeaPRwire.com) - AEM Holdings Ltd. (“AEM” or “the Group”), a global leader in test innovation, today announced the appointment of Kwek You-Cheer as its new Chief Financial Officer (“CFO”) with effect from 2 January 2025. Mr. Kwek has over 20 years’ experience in strategic financial leadership and operations internationally, which positions him well to guide AEM’s financial strategy and drive operational efficiency across the Group.Kwek You-CheerMr. Kwek joins AEM from Lenovo Group’s Asia Pacific Infrastructure Solutions Group (ISG), where he served as CFO. Prior to Lenovo, Mr. Kwek spent time as CFO at Microsoft Hong Kong and in a variety of finance roles in over a decade at Schneider Electric.Mr. Kwek graduated from Nanyang Technological University with a Bachelor of Accountancy (Honours).Ms. Amy Leong, Chief Executive Officer of AEM, commented, “We are pleased to have Mr. Kwek join the team, and believe his experience and knowledge will be an invaluable asset to the team in helping us achieve robust growth with a focus on improved operational efficiency.”About AEM Holdings Ltd.AEM is a global leader in test innovation. We provide the most comprehensive semiconductor and electronics test solutions based on the best-in-class technologies, processes, and customer support. AEM has a global presence across Asia, Europe, and the United States. With manufacturing plants located in Singapore, Malaysia (Penang), Indonesia (Batam), Vietnam, and Finland (Lieto), South Korea, and the United States (Tempe) and a global network of engineering support, sales offices, associates, and distributors, we offer our customers a robust and resilient ecosystem of test innovation and support.AEM Holdings Ltd. is listed on the main board of the Singapore Exchange (Reuters: AEM. SI; Bloomberg: AEM SP). AEM’s head office is in Singapore.Issued for and on behalf of AEM Holdings Ltd. by Financial PR Pte LtdFor more information please contact:Kamal SAMUEL / Shivam SARAFFinancial PR Pte LtdTel: 6438 2990 / Fax: 6438 0064E-mail: kamal@financialpr.com.sg / shivam@financialpr.com.sg Copyright 2025 ACN Newswire via SeaPRwire.com.

SINGAPORE, Jan 3, 2025 - (ACN Newswire via SeaPRwire.com) - People often associate the end of the year as a time to wind down, slow down and get into the New Year celebration mood – but surprisingly, around the world, research has shown that stress levels actually increases during the holiday season, with year-end work deadlines, last-minute shopping, loneliness, and increased travel commitments as a large contribution to the additional pressure. With 87% of Singaporeans already experiencing high stress levels throughout the year, the number spikes further as the close of the year creeps in.In the post-pandemic era, research has proven that there is an intrinsic link between stress, immune function, and vulnerability to illnesses. The higher stress one faces on a day-to-day basis, the weaker the immune function becomes. Increased social interactions, feasting and late nights also causes a strain on the immunity and overall well-being of individuals.For example, the prevalence of leisure sickness, falling ill during or immediately after vacations, has been the focus of many researchers – why do people fall sick after a holiday break? Leisure sickness is caused by a combination of chronic stress, disrupted routines, and exposure to pathogens unfamiliar to the body from foreign lands, which have been shown to leave individuals with a weakened immune system, further underscoring the need for immune support during the holidays.In light of the holiday season, LAC (pronounced as L-A-C), is dedicated to maintaining optimal stress and immunity levels among individuals, to allow them to fully enjoy and immerse themselves in the season of giving with its TriAction C 1000 - Timed-Release and its best-seller, LAC Masquelier’s French Pine Bark Extract.LAC TriAction C 1000 - Timed-Release is formulated to support the immune system and help mitigate the effects of stress and seasonal flu. Packed with a revolutionary Vitamin C formula, the advanced timed-release technology ensures that individuals receive the right amount of Vitamin C, enhancing vitality and fortifying the immune system to stay strong and healthy.Stress-induced free radicals can significantly weaken the immune system and damage cells in the body. Rich in powerful antioxidants, LAC Masquelier’s French Pine Bark Extract helps to neutralise these harmful free radicals, strengthening the body’s natural defenses, promoting resilience against viruses and maintaining overall-wellbeing. Copyright 2025 ACN Newswire via SeaPRwire.com.

香港, 2025年1月2日 - (亚太商讯 via SeaPRwire.com) - 经过多年的爆发式增长后，现制饮品市场的竞争依旧激烈。在众多品牌中，蜜雪冰城的表现引起了市场的关注。作为中国及全球最大的现制饮品龙头（以截至2024年9月30日门店数计），蜜雪冰城在规模、供应链、品牌力等方面构筑了良好的竞争优势，稳居行业领先地位。1月1日，蜜雪冰城更新港股A1招股书，其业务表现又有哪些新的突破？国内国外稳步扩张 门店数跃居全球第一随着行业度过跑马圈地的高速扩张期，如何挖掘新的业务增量，已成为头部品牌们面临的一道必答题。蜜雪冰城通过聚焦下沉与出海这两大极具发展潜力的市场，稳步推进其门店扩张战略，捕捉市场发展机遇。国内市场方面，蜜雪冰城凭借广泛的门店网络，持续渗透三四线以及乡镇下沉市场。截至2024年9月30日，公司在中国内地的门店数超过40,000家，覆盖超过300个地级市、1,700个县城和4,900个乡镇，其中超过23,000家位于三线及以下城市，占比达到57.2%。在国内稳居市场鳌头的同时，蜜雪冰城积极响应一带一路倡议，积极进军海外市场。截至2024年9月30日，公司在中国内地以外拥有约4,800家门店，包括印尼、越南、马来西亚、泰国、菲律宾、柬埔寨、老挝、新加坡、澳大利亚、韩国和日本11个国家以及香港和澳门地区。其中，越南和印尼两国开店数量分别超过1,300家及2,600家，成为公司国际化布局的主力。得益于国际国内的同步发力，2024前九个月，蜜雪冰城净增门店数超过7,700家（相较于2023年底）。截至2024年9月30日，公司门店数超过45,000家，就门店数量而言，蜜雪冰城已超越星巴克，成为中国以及全球最大的现制饮品企业。门店表现亮眼 业绩高基数之上延续增长值得一提的是，蜜雪冰城并非单纯追求门店数量的增长，而是经过深入研究市场需求、消费趋势之后的精心布局，这使其新开门店能够快速站稳脚跟，为可持续发展奠定坚实基础。从2024年前9个月的平均单店日均终端营业额看，2024年新开业的门店平均单店日均终端营业额表现不输老店。同时，蜜雪冰城老店的运营表现也十分稳健。得益于精准的市场洞察、持续的产品创新、高效的供应链管理以及强大的市场口碑，老店（2021年或之前开业门店）的平均单店日均终端营业额在2021年至2023年期间仍呈现年化4%以上的增长，2023年及以前开业的门店在2024年前九个月的平均单店日均终端营业额均超过2023年全年的水平。在高效门店扩张战略的支持下，蜜雪冰城在过往较高业绩基数的基础上，依然实现了收入、利润的双双增长，盈利能力进一步提升。2024年前9个月，实现收入人民币187亿元，同比增长超过21%；净利润人民币35亿元，同比增长超过42%。毛利率为32.4%，同比提升2.7个百分点；净利率为18.7%，同比提升2.8个百分点。中长期看，随着城镇化的持续推进以及居民收入水平的提升，现制饮品消费数量和消费能力将不断增长，为行业发展提供广阔的市场空间。蜜雪冰城以高性价比产品俘获用户心智，国内市场持续深耕下沉市场，将进一步巩固其领先优势，同时，国际化战略的深入推进也将为公司打造新的增长引擎。在国内国际市场共同驱动下，蜜雪冰城有望释放更大的增长弹性。 Copyright 2025 亚太商讯 via SeaPRwire.com.

香港, 2025年1月2日 - (亚太商讯 via SeaPRwire.com) - 纵横公共关系顾问集团 (简称「纵横公关集团」或「集团」) 今日欣然宣布正式迈入集团成立30周年的辉煌时刻。为纪念这一里程碑，集团推出各种活动以示庆祝，其中包括已于2024年底圆满落幕的30周年标志设计比赛。通过设计比赛的激烈角逐，一款印有「30」数字和地球元素的标志脱颖而出，它象征着集团全球布局之专业团队，以及为全球客户提供卓越服务的坚定承诺。这款标志将于2025 年起广泛应用于集团的各种宣传和推广材料，成为集团30周年志庆的标志性符号。2025年首个工作日，纵横公关集团以别出心裁的庆祝活动拉开周年志庆的序幕，为同事们准备了珍珠奶茶、茶点以及舒适的按摩服务，旨在为新的一年注入活力。纵横公关集团主席及创办人曾立基在庆典上表示：「珍珠的璀璨光泽，象征着时间的沉淀与磨砺，正如纵横公关集团经历30年来的蓬勃发展。在过去30年间，我们见证了全球政经格局的复杂多变，面对重重挑战，我们始终坚韧不拔。而正是这份韧性和适应能力，让我们不仅跨跃挑战，更从香港一间本地公司，跻身于亚太地区顶尖的公关集团之列，拥有旗下成员公司20家。我们的业务范畴也从最初专注的金融服务，扩展到更为全面的综合解决方案，使我们在瞬息万变的市场中独树一帜。」纵横公关集团一直致力于业务据点和范畴的扩展，同时坚守提供卓越服务和追求进步的核心精神。2024年，集团迈向研究领域的重要一步，由在研究范畴的专精学者带领，专注于环境、社会和管治(「ESG」)议题的研究。凭借团队的学术积累和对全球趋势的深刻洞察为客户提供更具针对性的专题调研，并据此制订解决方案。集团认为，这一新服务不仅能满足现有客户的需求，更能吸引更多潜在客户，推动集团业务向多元化发展。集团的创意服务和数位内容创作旗舰Strategic DigitaLab(简称「SDL」) (www.strategicdigitalab.com)自2017年成立以来，不断引领创新潮流。2024年，SDL更是致力于重塑品牌形象，凭借其卓越的叙事能力，在多元平台全面发力，成功带动客户寻求高效、大规模的内容创作服务，以满足、启发和鼓动目标受众。通过共享创意和数位能力，SDL使集团在瞬息万变的时代中占据先机，充分满足了各大客户的多样化需求。而为了配合在南半球的客户需要，集团于2024年全面收购了Financial & Corporate Relations Pty Limited (「FCR」) 。FCR是澳大利亚一家拥有40年历史的顾问公司，专注于投资者、企业及财经传讯领域。集团对这次收购充满期待，相信FCR将为集团带来业务上的全新突破。多年来，集团始终秉持对服务品质的极致追求，也因此收获了超过540个奖项和殊荣，包括亚太区最佳公关集团、最佳公关顾问(亚太区及亚洲)、大中华最佳独立顾问公司、香港最佳公关顾问、亚太区最佳财经公关顾问、最佳危机管理团队及市场领袖大奖等。集团主席曾立基表示：「感谢每一位同事的坚持不懈和团队的合作无间，让我们能够济济一堂共同庆祝30周年这一重要时刻。展望未来，集团将继续在公关领域精益求精，寻求创新，不断提升服务品质，积极拥抱自动化和新科技；为团队提供全面的培训，并积极探索新的业务领域。同时，作为企业公民的坚定倡导者，我们也将继续积极参与公益活动和义务公关工作，为社会贡献我们的力量。」关于纵横公共关系顾问集团 (「纵横公关集团」)纵横公关集团于1995年在香港成立之时以投资者关系服务为核心，至今已发展成为辐射亚太区、服务本地及国际客户的综合公关顾问。集团在亚太区8大据点聘有超过250名公关专才，同时透过分布世界各地的伙伴和PROI Worldwide，在逾165个城市为客户提供一站式综合传讯服务。 欢迎流览网站: www.sprg.asia垂询 纵横财经公关顾问有限公司 温淑贤电话: (852) 2864 4822电邮: eveline.wan@sprg.com.hk网址: www.sprg.asia 香港 | 北京 | 上海 | 广州 | 台北 | 新加坡 | 吉隆玻 | 悉尼 Copyright 2025 亚太商讯 via SeaPRwire.com.

上海, 2025年1月2日 - (亚太商讯 via SeaPRwire.com) - 云顶新耀（HKEX 1952.HK）是一家专注于创新药研发、临床开发、制造和商业化的生物制药公司，今日宣布随着《国家基本医疗保险、工伤保险和生育保险药品目录（2024年）》（"国家医保药品目录"）2025年1月1日正式实施，耐赋康(R)（布地奈德肠溶胶囊，NEFECON(R)）将开始执行医保新价格，各地IgA肾病患者将陆续享受医保报销。耐赋康(R)于2024年11月被纳入国家医保药品目录。作为全球首个获得美国食品药品监督管理局（FDA）和欧洲药品管理局（EMA）完全批准的IgA肾病治疗药物，耐赋康(R)于2023年11月通过优先审评程序正式获得中国国家药品监督管理局的批准，用于治疗具有进展风险的原发性IgA肾病成人患者，是中国唯一获得IgA肾病适应症的治疗药物。根据国家医保局要求，耐赋康(R)将于1月开始在北京、上海等各省市执行医保报销，患者可在定点医疗机构或定点药店购药，并享受医保报销价格。国家医保药品目录的正式实施将提升耐赋康(R)的可及性，减轻患者负担，使更多中国IgA肾病患者从这款创新药物中获益。耐赋康(R)全球III期临床试验NefIgArd研究中国人群数据分析显示，耐赋康(R)减少66%的肾功能下降，预估可将疾病进展至透析或肾移植的时间延缓12.8年。凭借创新的作用机制和临床优势，耐赋康(R)已经得到了国内外多个权威治疗指南的推荐，包括被纳入由改善全球肾脏病预后组织（KDIGO）发布的《2024版KDIGO IgA肾病和IgA血管炎临床管理实践指南（公开审查版）》，并被指是迄今为止唯一被证明可以降低致病性IgA和IgA免疫复合物水平的治疗方法。关于耐赋康(R)（NEFECON(R)）耐赋康(R)(NEFECON(R))是布地奈德肠溶胶囊，作为全球首个对因治疗IgA肾病的药物，是靶向肠道黏膜B细胞的免疫调节剂，能减少50%肾功能下降1，在中国人群中能延缓肾功能衰退达66%2，预计将疾病进展至透析或肾移植的时间延缓12.8年3。同时布地奈德首过代谢程度达90%4，具有良好的安全性。耐赋康(R)专为IgA肾病患者研制，每颗胶囊含布地奈德4mg，通过特殊的迟释及缓释双重制剂工艺，将布地奈德靶向释放于回肠末端的黏膜B细胞（包括派尔集合淋巴结），胶囊溶解后，三层包衣微丸持续稳定释放布地奈德，高浓度覆盖整个靶区域，从而减少诱发IgA肾病的半乳糖缺陷的IgA1抗体（Gd-IgA1）产生，进而干预发病机制上游阶段，达到治疗IgA肾病的作用。2019年6月，云顶新耀与Calliditas Therapeutics 签订独家授权许可协议，获得在大中华地区和新加坡开发以及商业化耐赋康(R)的权利。该协议于2022年3月扩展，将韩国纳入云顶新耀的授权许可范围。关于云顶新耀云顶新耀是一家专注于创新药和疫苗研发、临床开发、制造和商业化的生物制药公司，致力于满足亚洲市场尚未满足的医疗需求。云顶新耀的管理团队在中国及全球领先制药企业从事过高质量研发、临床开发、药政事务、化学制造与控制（CMC）、业务发展和商业化运营，拥有深厚的专长和丰富的经验。云顶新耀已打造多款疾病首创或者同类最佳的药物组合，公司的治疗领域包括肾科疾病、感染性和传染性疾病、自身免疫性疾病。有关更多信息，请访问公司网站：www.everestmedicines.com。前瞻性声明本新闻稿所发布的信息中可能会包含某些前瞻性表述，乃基于本公司或管理层在做出表述时对公司业务运营情况及财务状况的现有看法、相信、和现有预期，可能会使用"将"、"预期"、"预测"、"期望"、"打算"、"计划"、"相信"、"预估"、"确信"及其他类似词语进行表述。这些前瞻性表述并非对未来业绩的保证，会受到风险、不确定性及其他因素的影响，有些乃超出本公司的控制范围，难以预计。因此，受我们的业务、竞争环境、政治、经济、法律和社会情况的未来变化及发展等各种因素及假设的影响，实际结果可能会与前瞻性表述所含资料有较大差别。本公司及各附属公司、各位董事、管理人员、顾问及代理未曾且概不承担更新该稿件所载前瞻性表述以反映在本新闻稿发布日后最新信息、未来项目或情形的任何义务，除非法律要求。参考文献1.Lafayette R,et al. Lancet. 2023 Sep 9;402(10405):859-870.2.2023ASN. Oral presentation.3.Jonathan Barratt,et al. 2023 ASN. Poster no. SA-PO886.4.Edsbäcker S,et al. Aliment Pharmacol Ther. 1999 Feb;13(2):219-24. Copyright 2025 亚太商讯 via SeaPRwire.com.

HONG KONG, Jan 2, 2025 - (ACN Newswire via SeaPRwire.com) – Strategic Public Relations Group (“SPRG” or the “Group”) proudly announces its transition into its 30th year of development – a significant milestone in its business journey. To celebrate, the Group will organise various events and activities, including a 30th Anniversary Logo Design Contest that was held at the end of 2024. The logo with the “30” and globe will be used in various SPRG materials in 2025 and represent the Group’s commitment to delivering the best services to clients via its global reach and international talent pool. To kick off the anniversary of SPRG, colleagues are offered bubble tea, refreshments and massages on their first working day of the new year.Richard Tsang, Founder and Chairman of SPRG, said, “The chewy bubbles represent pearls, which fit perfectly with our 30th anniversary theme. Just as pearls take time to form and develop their lustre, SPRG has over time developed and grown in stature. In the past 30 years, we have navigated a complex and ever-changing global political and economic landscape. We have had to face each challenge with agility, resilience and unwavering commitment, and these qualities have enabled SPRG to evolve from a local office in Hong Kong into one of the largest PR groups in the APAC region, boasting a cohesive family of 20 member companies. This evolution has enabled us to expand our services beyond a strong foundation in financial services to a broader range of integrated solutions, setting us apart in a dynamic marketplace.”SPRG has consistently bolstered its presence and scope while remaining committed to delivering exceptional services and pursuing continuous advancement. In 2024, the Group added research capabilities as its latest offering, which will be led by a university professor specialising in research, particularly on environmental, social, and governance (ESG) issues. With academic backing and an in-depth understanding of global trends, SPRG will conduct targeted surveys and research to provide tailored solutions to clients and the community. SPRG believes that such endeavours will not only meet the evolving needs of existing clients, but will also attract new ones, as well as further diversify the Group’s service offerings.In line with its service diversification efforts, SPRG launched Strategic DigitaLab (SDL) In 2024, the Group took a significant step forward by refreshing the SDL brand image. With exceptional storytelling capabilities, SDL excels across multiple platforms, attracting clients seeking large-scale content creation services that engage and inspire their target audiences. By harnessing collaborative creativity and digital expertise, SPRG is well positioned to seize early opportunities and meet the demands of major clients in this rapidly evolving landscape.In 2024, SPRG also sharpened its competitive edge by acquiring full ownership of Financial & Corporate Relations Pty Limited (FCR), an IR/financial communications agency with a 40-year legacy based in Sydney, Australia. This acquisition enhances the Group's ability to serve clients in the southern hemisphere, and SPRG looks forward to achieving breakthroughs with FCR's support.SPRG’s commitment to excellence has resulted in over 540 awards and accolades received since its inception, including Asia Pacific Network of the Year, Public Relations Agency of the Year in Asia Pacific, Public Relations Agency of the Year in Asia, Greater China Independent Agency of the Year, Hong Kong Consultancy of the Year, Asia Pacific Financial Consultancy of the Year, Best Crisis Management Team, and Market Leadership in Public Relations, etc. “We would not be celebrating our 30th anniversary and the many successes that have come without the steadfast dedication and teamwork of our colleagues”, said Richard. “As SPRG embarks on a new chapter of development, we will remain committed to excellence and innovation in the public relations industry. In the future, we will continue to enhance service offerings, embrace automation and technology, and offer training and exposure to our teams. The Group is also a staunch advocate of corporate citizenship and will continue to be actively involved in charitable initiatives and pro bono projects that benefit society.”About Strategic Public Relations Group (“SPRG”)Established in 1995 as an investor relations specialist in Hong Kong, SPRG has grown to become an integrated PR group that prides itself on providing exceptional services to local and international clients in Asia Pacific. SPRG has 250 professionals working from eight locations across APAC, providing clients with holistic communications services. With affiliates around the world and PROI Worldwide partners, SPRG can help clients access over 165 cities globally. Visit www.sprg.asia for more information.EnquiriesStrategic Public Relations GroupEveline WANTel: (852) 2864 4822Email: eveline.wan@sprg.com.hkWebsite: www.sprg.asiaHong Kong | Beijing | Shanghai | Guangzhou | Taipei | Singapore | Kuala Lumpur | Sydney Copyright 2025 ACN Newswire via SeaPRwire.com.

- Themed “New Play for All”, the three international events bring together over 2,500 exhibitors from 34 countries and regions- Toys & Games Fair's Electronic & Remote Control Toys and Educational Toys & Games zones have expanded, in addition to the debut of an ESG pavilion- Record number of exhibitors at Hong Kong Baby Products Fair- HKTDC organised over 200 buying missions from more than 40 countries and regions to Hong Kong for sourcingHONG KONG, Jan 2, 2025 - (ACN Newswire via SeaPRwire.com) – Kicking off a brand new year, the 51st HKTDC Hong Kong Toys & Games Fair, the 16th HKTDC Hong Kong Baby Products Fair and the 23rd Hong Kong International Stationery & School Supplies Fair will all be held at the Hong Kong Convention and Exhibition Centre from 6 to 9 January. The Hong Kong Toys & Games Fair and Hong Kong Baby Products Fair are organised by the Hong Kong Trade Development Council (HKTDC), while the Hong Kong International Stationery & School Supplies Fair is jointly organised by the HKTDC and Messe Frankfurt (HK) Ltd.Sophia Chong, HKTDC Deputy Executive Director, said: “Themed New Play for All, the three fairs attracted more than 2,500 exhibitors from 34 countries and regions, including pavilions from Hong Kong, Mainland China, Taiwan, Korea, and Europe. We have also invited more than 200 buying missions from over 40 countries and regions to Hong Kong for sourcing, creating new opportunities for the industry and injecting new momentum into Hong Kong's economic development.The Toys & Games Fair and Baby Products Fair continue to feature the popular ‘Brand Name Gallery’, with 40% more brands compared to last year, and totalling more than 380 famous toys, baby and children's brands, enabling buyers to source the latest designs and quality products.”Asia's flagship toy fair sees expansion in two major exhibition zonesAs the flagship toy fair in Asia and the HKTDC’s first trade show of the year, the Hong Kong Toys & Games Fair, along with the Hong Kong Baby Products Fair and the Hong Kong International Stationery & School Supplies Fair, bring cross-industry business opportunities to visitors from diverse sectors.This year's Toys & Games Fair sees an expansion in exhibition space in two major zones. This includes the Electronic & Remote Control Toys and Educational Toys & Games zones.The Green Toys zone makes a welcome return and will showcase eco-friendly and innovative products.In addition, many exhibitors have introduced toys that incorporate green elements and promote environmental awareness in recent years. Both the Toys & Games Fair and the Stationery & School Supplies Fair will feature "Green Leaf" label on-site to facilitate buyers in sourcing related products.Funded by the Trade and Industrial Organisation Support Fund of the Trade and Industry Department, HKSAR Government, the Toys Manufacturers’ Association of Hong Kong and FHKI Group 19 (Hong Kong Toys Council) will present the first ESG Pavilion showcasing toys incorporating Environment, Social and Governance (ESG) elements, including products made entirely from eco-friendly or recycled materials. Exhibitors are using various creative methods to promote sustainable development, emphasising the value of social responsibility and ESG fundamentals.This year’s Toys Fair has an impressive pavilion lineup, including those from Mainland China, Taiwan, Korea, and the Spielwarenmesse eG’s World of Toys Pavilion which will host various European exhibitors. The Hong Kong Brand Toy Association (HKBTA) Pavilion once again promotes the local creative industry and trendy toy products to international buyers.The Smart Tech Toys & Games zone will feature tech products operated by applications, incorporating virtual reality (VR), augmented reality (AR), mixed reality (MR) and other technologies. Kidult World will showcase toys specifically designed for adults with a childlike spirit, such as collectibles, magic props, models, and puppets.Record number of exhibitors at Baby Products FairWith more than 660 exhibitors, this year's Hong Kong Baby Products Fair boasts the most exhibitors ever. The popular ODM Strollers and Gear zone continues for the second consecutive year, featuring over 80 exhibitors, making it easier than ever for buyers to source products from original design manufacturers. The Selection of Europe pavilion returns and will feature, for the first time, the UK’s Baby Products Industry Association putting a spotlight on quality European baby brands and products. This year sees the return of several popular pavilions, such as the well-known Korean and Hong Kong Children, Babies, Maternity Industries Association pavilions. Making their debut this year is the Zhejiang Zhili pavilion which will present an array of high-quality infant and children’s clothing.The Toys & Games Fair and Baby Products Fair continue to feature the popular Brand Name Gallery, bringing together over 380 well-known brands from around the globe, allowing buyers to source the latest designs and high-quality products from a variety of brands.Jointly organised by the HKTDC and Messe Frankfurt (HK) Ltd, the Hong Kong International Stationery & School Supplies Fair will feature the latest school and office supplies, creative art supplies and gift stationery. The organisers continue to cooperate with renowned industry associations in different regions, including China Stationery & Sporting Goods Association, Malaysia Stationery Importers and Exporters Association and The Federation of Stationers and Booksellers Association of Malaysia.Asian Toys & Games Forum and various seminars help the industry seize opportunitiesHelping buyers and sellers broaden their business networks and learn about the most recent market trends, there are a number of networking events, buyer forums, product demo and launch pad, and seminars throughout the fair period.On the second day of the fair, the Asian Toys & Games Forum will be held. Themed Beyond Fun and Play: Fostering Social Responsibility in the Toy Industry, international toy and game industry experts will discuss the role of toys and games in therapy, healthcare and wellness, and their impact on socialisation and active ageing. Other seminars will cover popular topics such as toy safety regulations, toy sustainability, and gender-based perspectives and inclusivity in the toy market.The three exhibitions offer buyers a one-stop sourcing platform, creating more cross-industry business opportunities. Under the EXHIBITION+ model, the fairs integrate physical exhibition and the Click2Match smart business matching platform for online business meetings. The online exhibition will be early accessible from 30 December 2024 until 16 January 2025, to sustain and create greater business opportunities for the industry. Buyers can also scan QR codes at exhibitor booths using the Scan2Match service to bookmark their favourite exhibitors, browse product information and engage with exhibitors even after the fair to make for more business connections.Photo Download:https://bit.ly/4fLhGt0Sophia Chong, HKTDC Deputy Executive Director (centre), Bryant Chan, Chairman of the HKTDC Toys Advisory Committee (left) and Judy Cheung, Deputy General Manager of Messe Frankfurt (HK) Ltd (right), attended the press conference presenting highlights and innovative products of the Toys & Games Fair, Baby Products Fair and Stationery & School Supplies Fair, which will open next Monday (6 January).One green toy at the Toys & Games Fair is the “Voice of Nature” 3D paper puzzle. The product comes with multiple movable joints. By gently shaking the product, it mimics the sound of animals. The puzzle, instruction manual and packaging are all made from pure wood pulp kraft paper, making the entire product recyclable and minimising environmental damage.The officially authorised 1/64 scale Super Car Collection Lamborghini Essenza SCV12 model.Gateway Space Station Interactive Model is a STEM learning toy, and a detailed replica of Gateway; a part of the NASA Artemis project.An exhibitor at the Baby Products Fair showcases the lightweight and portable 2anagels Silicone Diamond Suction Baby Bowl, which is designed and made in Taiwan, featuring a patented interlocking design, certified by German LFGB, with heat resistance up to 220°C.Exhibitor at the Stationery & School Supplies Fair showcases a school backpack with a fused lunch bag, featuring a spacious main compartment for books and supplies, while the integrated lunch bag keeps snacks fresh and easily accessible.Fair WebsitesHKTDC Hong Kong Toys & Games Fair: hktoyfair.hktdc.comHKTDC Hong Kong Baby Products Fair: hkbabyfair.hktdc.comHong Kong International Stationery & School Supplies Fair: hkstationeryfair.comRegister for free entry pass: https://tinyurl.com/eb3w32p8Media enquiresPlease contact HKTDC’s Communication & Public Affairs Department:Sharon HaTel:2584 4575Email:sharon.mt.ha@hktdc.orgJane CheungTel:2584 4137 Email:jane.mh.cheung@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 51 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.

SHANGHAI, China - January 2, 2025 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that with the official implementation of the latest update of the National Reimbursement Drug List ("NRDL") on January 1, 2025, NEFECON(R) will apply the NRDL pricing, which will benefit more IgA nephropathy (IgAN) patients.NEFECON(R) was included in the NRDL in November 2024. As the first IgAN etiological treatment drug fully approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), NEFECON(R) received NDA approval from the National Medical Products Administration (NMPA) of China in November 2023 through Priority Review. It is the only approved treatment for primary IgAN in adults at risk of disease progression in China.Based on policies in various provinces and cities, NEFECON(R) will be eligible for NRDL reimbursement starting in January. Patients will be able to obtain the medication at designated medical institutions or pharmacies and benefit from the reimbursed pricing. The official implementation of the NRDL will expand the accessibility of NEFECON(R), alleviate the financial burden on patients, and enable more IgAN patients in China to benefit from this innovative drug.Results from the Chinese population of the Phase 3 clinical study NefIgArd study shows that NEFECON(R) reduces kidney function decline by 66%, and delays disease progression to dialysis or kidney transplantation by 12.8 years. With its innovative mechanism of action and clinical advantages, NEFECON(R) has been recommended by several authoritative treatment guidelines. Most recently, it was included in the KDIGO 2024 Clinical Practice Guideline for the Management of Immunoglobulin A Nephrophthy (IgAN) and Immunoglobulin A Vasculitis (IgAV) (Public Review Draft), issued by the kidney disease: Improving Global Outcomes (KDIGO) organization.About NEFECON(R)NEFECON(R) is a patented oral, delayed release formulation of budesonide, a corticosteroid with potent glucocorticoid activity and weak mineralocorticoid activity that undergoes substantial first pass metabolism. The formulation is designed as a delayed release capsule that is enteric coated so that it remains intact until it releases budesonide to the distal ileum. Each capsule contains coated beads of budesonide that target mucosal B-cells present in the ileum where the disease originates, as per the predominant pathogenesis models.In June 2019, Everest Medicines entered into an exclusive, royalty-bearing license agreement with Calliditas Therapeutics, which gives Everest Medicines exclusive rights to develop and commercialize NEFECON(R) in mainland China, Hong Kong, Macau, Taiwan, China and Singapore. The agreement was extended in March 2022 to include South Korea as part of Everest Medicine's territories.About Everest MedicinesEverest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record from both leading global pharmaceutical companies and local Chinese pharmaceutical companies in high-quality discovery, clinical development, regulatory affairs, CMC, business development and operations. Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company's core therapeutic areas of renal diseases, infectious diseases and autoimmune disorders. For more information, please visit its website atwww.everestmedicines.com.Forward-Looking Statements:This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as 'will,' 'expects,' 'anticipates,' 'future,' 'intends,' 'plans,' 'believes,' 'estimates,' 'confident' and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law. Copyright 2025 ACN Newswire via SeaPRwire.com.

WINCHESTER, ENGLAND, Jan 3, 2025 - (ACN Newswire via SeaPRwire.com) - Millions of people try vegan diets each January as part of the global Veganuary campaign. In 2024, roughly 25 million people sought a fresh start for their health and the environment through vegan diets. Yet in the decade since Veganuary was founded in 2014, dogs and cats have been almost entirely excluded. Now however, veterinary Professor Andrew Knight is calling for Veganuary to be extended to pets.Writing in The Conversation, Knight notes that dogs and cats may also experience health benefits associated with vegan diets: "By late 2024, 11 studies in dogs, three in cats, and one systematic review covering both had all demonstrated that dogs and cats thrive on modern vegan or vegetarian diets. Certain health benefits appear consistent, such as a reduction in obesity and of conditions that may be triggered by animal-sourced allergens, like itchy skin and ears and gastrointestinal problems." However, he notes that "all diets, including vegan diets, should be manufactured by reputable pet food companies which carefully formulate their food to be nutritionally sound."Professor Knight is a very experienced dog and cat veterinarian with a PhD in vegan pet food. His most recent study examined the environmental benefits of such diets. These shattered long-standing assumptions that it is only people who need to change their diets for environmental reasons.Knight found that in nations with high pet ownership - such as the US, pet food consumes around 20% of all land animals killed for food, as well as billions of fish and marine animals. Globally, it's around 9% - even after accounting for the use of by-products of human food production.This means at least six billion land animals are killed each year to feed the world's approximately 470 million pet dogs. Use of nutritionally sound vegan dog food would provide enormous savings of land and fresh water, which could be used for reforestation, re-wilding, biodiversity increase, and carbon capture. It would spare a staggering 0.57 gigatonnes (1 gigatonne is 1 billion tonnes) of CO2-equivalent greenhouse gases each year - 1.5 times the 0.38 gigatonnes emitted by the whole of the UK in 2023.Because most plant calories fed to livestock animals are lost during conversion to meat, milk or eggs, directly consuming plant-based ingredients can also save food energy. A global transition to vegan dog food would spare sufficient food energy to feed around 450 million people annually - or the entire human population of the EU.Sustainability benefits are large even considering the world's roughly 370 million pet cats. A global transition to nutritionally sound vegan cat food would spare sufficient food energy to feed around 70 million people annually - larger than the human population of the UK.Said Knight, "An average-sized dog can consume as much meat as a person. If you want better health and environmental outcomes in 2025, try Veganuary - and please don't forget your pets!" Advice is available via his website.Contact InformationAndrew KnightVeterinary Professor of Animal Welfareandrew.knight@murdoch.edu.auSOURCE: Representing Animals Foundation Copyright 2025 ACN Newswire via SeaPRwire.com.

香港, 2024年12月31日 - (亚太商讯 via SeaPRwire.com) - 国际知名评级机构标普全球（S&P Global）近期发布了国泰君安国际控股有限公司（"国泰君安国际"或"公司"，股份代号：1788.HK）最新企业可持续发展评估（Corporate Sustainability Assessment，简称CSA）报告。报告显示，国泰君安国际CSA评分相较于上一次评估实现了7分的稳步提升，在行业中表现卓越。据报告，国泰君安国际在ESG三大维度（管治与经济维度，社会维度及环境维度）中均取得优异成绩，本次得分提升是由于公司在气候战略、人力资本管理和商业道德这三个关键领域领先于行业平均水平。其中，标普全球特别肯定了公司在商业道德实践方面的出色表现，并指出公司在必要披露和自愿披露方面的有效信息量及内容在金融服务行业中处于较高水平，这表明公司在ESG信息披露透明度方面做出了积极努力。国泰君安国际一直以来高度重视ESG议题，将其融入日常运营和管理之中。2024年，公司MSCI ESG获提升至"A"级，国内知名评级机构万得Wind ESG和商道融绿ESG均授予公司行业领先的"A"评级。通过不断优化提升，国泰君安国际在ESG领域的表现获得业内广泛认可，这不仅是对公司努力的肯定，也将进一步推动公司在ESG方面的发展。随着ESG在投资者决策中的地位不断提升，国泰君安国际出色的ESG实力无疑将为公司未来发展带来更多机遇。 Copyright 2024 亚太商讯 via SeaPRwire.com.

香港, 2024年12月31日 - (亚太商讯 via SeaPRwire.com) - 中国船舶环保设备及系统提供商 - 上海汇舸环保科技集团股份有限公司（「汇舸环保」或「集团」，股份代号：2613），今天宣布于香港联合交易所有限公司（「香港交易所」）主板上市计划。汇舸环保将全球发售10,000,000股H股，其中1,000,000股H股将作香港发售（可予重新分配），占初步发售股份总数10%；9,000,000股H股将于国际发售（可予重新分配），占初步发售股份总数90%，发售价介乎31.8港元至39.8港元。汇舸环保将于2024年12月31日（星期二）早上9时正，开始于香港公开发售，并于2025年1月6日（星期一）中午12时截止。集团的股份预计将于2025年1月9日（星期四）于香港联交所主板开始买卖，股份将按每手买卖单位100股买卖，股份代号为2613。中信证券（香港）有限公司及中国银河国际证券（香港）有限公司为联席保荐人、整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人。法国巴黎证券（亚洲）有限公司为整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人。汇舸环保是一家中国船舶环保设备及系统提供商，服务世界各地的航运公司及船东客户。根据弗若斯特沙利文的资料，于二零二三年十二月三十一日，按船舶废气净化系统的二零二三年已完成订单总数及累计手头订单量计，集团在中国船舶废气净化系统提供商中排名第三，在全球所有船舶废气净化系统提供商中排名第四。集团于二零一七年开展业务，推出首款产品船舶废气净化系统。现已开发及商业化销售多种船舶环保设备及系统。具体而言，集团的设备及系统旨在帮助客户（例如船东）减少硫化物及GHG 排放。此外，集团通过提供内部设计以及供应设备及系统来提高船上生活条件及加强海事作业，旨在帮助客户改善其船员的生活质素。受惠于ESG监管框架及海洋环境保护相关倡议所带动日益壮大的全球市场作为船舶环境保护设备及系统提供商，汇舸环保受惠于日趋严格的ESG 监管框架及海洋环境保护相关倡议所带动的日益壮大的全球市场。汇舸环保的设备及系统助力集团的客户追求更高效及可持续的商业运营。对集团设备及系统的需求亦受到各种ESG 相关要求的带动。例如，国际海事组织将燃料油的硫上限设定为0.5%，自二零二零年起生效，并推出EEXI 及CII 等措施，自二零二三年起生效。于二零二三年七月七日，国际海事组织修订了其GHG 减排战略，其目标是到二零五零年实现净零排放的中长期里程碑。此外，欧洲联盟从二零二四年开始引入欧盟航运排放交易系统，以及即将出台的二零二五年FuleEU 海事法规。不断发展的ESG监管框架为集团的设备及系统的销售增长做出了贡献，并将继续做出贡献。研发及创新能力，捕获快速变化的市场需求集团的研发及创新能力使其能够快速回应市场需求，开发新设备及系统，帮助船东和造船商应对不断演进的环保要求以及彼等的独特需求。例如，集团的产品船舶废气净化系统已经历四代升级，每一代在脱硫效率方面均有所提升。集团船舶废气净化系统的核心部件脱硫塔具有轻量化设计特点，可降低船舶的功耗。为缩短安装时间，节省船东船舶运作中断的时间和成本，集团已对产品进行模组化。汇舸环保位于上海及里斯本的研发团队还利用各自的优势合作建立不同研发阶段的设备及系统及交换研发成就。两个研发团队各自均可独立展开研发工作，对集团的创新战略至关重要。强大的全球服务网络，服务多元优质的客户群汇舸环保位于上海的服务中心及中国附属公司为国内及全球市场提供服务。集团位于新加坡的服务中心为东南亚市场提供服务。集团通过服务承包商提供全球服务，包括亚洲、欧洲、美洲及中东。汇舸环保的服务中心负责在集团的全球服务网络提供客户服务及技术指导，且其还进行营销活动。通过全球服务网络，集团为客户提供从售前技术咨询到售后维护的服务，已培育一个全球服务网络。汇舸环保致力保持快速响应的沟通渠道，确保全天候确认并解决客户反馈的问题。集团的客户群现在遍布多个国家及地区，包括亚洲、欧洲、美洲及中东，展示了汇舸环保的全球影响力和客户对集团设备及系统的信任。全方位的定制型船舶环境保护设备及系统集团是拥有不仅涵盖船舶脱硫系统、船舶节能装置及船舶清洁能源供应系统，同时还提供涵盖社会层面的海事服务（包括船舶内装，以改善船员的工作及生活环境）的成套设备及系统的少数从业者之一。凭借全面的产品组合，集团能够按照客户的独特需求为彼等提供定制的设备及系统组合。集团定制化方法对客户有利，因为其使集团能够客制化设备及系统，从而满足不同船舶的不同规格和技术要求。每套设备及系统均可进行定制，以符合个别的船舶类型、客户需求、航线及船舶登记，集团定制从理解客户需求开始，到进行现场3D扫描建模，形成技术建议及图纸，其后提交至船级社及客户供审查和认证，最后进行采购、制造、安装及调试。强大的供应链管理能力及严格的质量控制汇舸环保具备强大的供应链管理能力，该能力垂直整合集团设备及系统的所有关键组成部分。这进而亦确保了质量的控制。集团向国内外知名供应商采购零部件及原材料，包括海水泵，水质分析仪，烟气分析仪，以及氮气系统。汇舸环保的供应链能力使集团能够对成本、质量及进度保持控制权，确保可靠及具成本效益的设备及系统开发及业务运营。集团已建立产品质量控制体系且集团的生产设施已从包括法国船级社及劳氏船级社在内的主要船级社获得对船舶废气净化系统及相关产品的工厂认证。集团的其他产品已获得包括美国船级社、劳氏船级社、挪威船级社、法国船级社、日本海事学会及中国船级社在内的主要船级社的认证。汇舸环保采用「以销定产」模式，使集团的生产计划与销售订单量保持一致。此举最大限度地减少了生产过剩和库存过剩的风险。上海汇舸环保科技集团股份有限公司CONTIOCEAN ENVIRONMENT TECH GROUP CO., LTD.资料摘要全球发售详情：全球发售之股份数目:10,000,000股H股香港发售股份数目:1,000,000股H股(可予重新分配)国际发售股份数目:9,000,000股H股(可予重新分配)最高发售价:每股H股39.8港元，另加1%的经纪佣金、0.0027%证监会交易征费、0.00015%会财局交易征费及0.00565%联交所交易费（须于申请时以港元缴足，多缴股款视乎最终定价可予退还）每手买卖单位:100 股H股香港公开发售开始:2024年12月31日(星期二) 上午9时香港公开发售结束公布股份配售和发售结果::2025年1月6日(星期一) 中午12时2025年1月8日(星期三)预计上市日期:2025年1月9日(星期四)股份代号:2613所得款项用途：经扣除就全球发售应付的包销佣金及其他估计开支后，按发售价为每股H股35.8港元（指示性发售价范围的中位数）计算，公司估计将自全球发售收取所得款项净额约312.0百万港元，并计划作下列用途：- 约50.0%（或156.0百万港元）将用于研发。- 约15.0%（或46.8百万港元）将用于潜在并购。- 约15.0%（或46.8百万港元）将用于投资在中国内地或东南亚设立生产设施。此外，亦会就生产设施采购制造及仓储物流设备，并购置信息技术软件和硬件。- 约10.0%或31.2百万港元将用于在国际上设立四间服务中心，包括亚洲、欧洲及中东。公司亦会升级服务中心。- 约10.0%（或31.2百万港元）将用作营运资金及一般企业用途。此新闻稿由博达浩华国际财经传讯集团代表上海汇舸环保科技集团股份有限公司发布。如有垂询，请联络︰博达浩华国际财经传讯集团冯嘉莉+852 3150 6763kelly.fung@h-advisors.global杨冬梅+86 150 2184 0493may.yang@h-advisors.global薛颖心+852 3150 6782bonnie.xue@h-advisors.global Copyright 2024 亚太商讯 via SeaPRwire.com.

HONG KONG, Dec 30, 2024 - (ACN Newswire via SeaPRwire.com) – Hong Kong's healthcare engineering sectors have actively responded to the Hong Kong SAR Government's efforts to promote advanced and modern construction technologies for fostering efficient building construction practices. In 2020, the industry adopted the innovative “Modular Integrated Construction” (MiC) technology, coupled with the “Multi-trade Integrated Mechanical, Electrical and Plumbing” (MiMEP) construction method, to construct the world’s first high-standard negative-pressure isolation ward module that could be assembled and deployed fast and easy. The module was repurposed for anti-epidemic use during the first wave of the COVID-19 pandemic that year. After the pandemic, the negative-pressure isolation ward module was put on public display at the CIC-Zero Carbon Park in Kowloon Bay to promote the MiC construction method. When the about two-year display ends in 2025, parts of the module will be recycled for purposes including reuse and further research. The project has demonstrated the immense potential of innovative engineering technologies in serving public health needs and laid a solid foundation for modular design in constructing infectious disease isolation facilities.The engineering sector in Hong Kong putting all heads together, applying innovative thinking and technologies, contributed to the fight against the COVID-19 pandemic raging in 2020. It took the industry only four months, starting from initial sketching to completing the project, to deliver in May 2020 a negative-pressure isolation ward meets hospital-grade standards, the first of its kind globally and was later hailed as the “Hong Kong version of Huoshenshan Hospital.” The facility exemplified the professionalism, innovative spirit, and rapid crisis response capabilities of Hong Kong’s engineering sector. Moreover, it has provided a significant reference model for the concerned global community in addressing similar events.The project used advanced MiC technology, plus the MiMEP construction method, which together significantly enhanced construction efficiency, shortening the entire construction cycle to just about a month. MiC technology enabled close to 80% of the construction process to be prefabricated in factories before being transported to the site for rapid assembly, adjustment, and testing. The approach not only drastically reduced on-site construction time, but also ensured high-quality standards and sustainability. Rigorous ventilation tests verified that the isolation ward could provide an effective negative-pressure environment, efficiently blocking the spread of highly infectious airborne viral particles. A distinctive feature of the design is it does not rely on a centralised air conditioning system with extensive external ventilation ducts. Instead, the MiMEP system's built-in ventilation and air conditioning provide a self-sufficient airflow design, effectively controlling infection. Given her limited land resources, Hong Kong needs designs that can fit into small spaces, and the project was then a “highly condensed design” unprecedented in the world.Ir Prof P L YUEN, Past President of the Hong Kong Institution of Engineers (HKIE), Past Vice President of the United Kingdom Chartered Institution of Building Services Engineers (CIBSE), and Chairman of the Hong Kong Branch of the United Kingdom Institute of Healthcare Engineering and Estate Management (IHEEM), said, “Inspired by the country’s 'Huoshenshan' project at the time, we began exploring how to construct high-standard isolation wards for limited spaces. The design required interlocking double-door control to precisely regulate airflow. To ease transportation, using the dimensions like those of a standard shipping container in our blueprint was an ideal option. By integrating MiC and MiMEP construction methods, we achieved a self-sufficient ventilation and air-conditioning design for the ward, matching with a compact electrical and mechanical module to supply its power and other engineering services demand. That innovative design was also the world’s first at the time." Prof Yuen also shared this design with fellow engineers, fostering collaboration to construct more suitable isolation facilities.Professor Yuen added, "The successful project shows that engineering innovation has a vital role to play in addressing public health challenges. While this project has fulfilled its historical mission, it is not the end. I hope it will encourage wider adoption of the proven method, novel and efficient, in other advanced building projects, which the Government is keen to promote. Furthermore, I hope it will inspire more local engineers to embrace innovation and technology, and together show and tell the many success stories of Hong Kong engineering."Ir Prof P L Yuen, Past President of the Hong Kong Institution of Engineers(HKIE), Past Vice President of the United Kingdom Chartered Institution ofBuilding Services Engineers (CIBSE), and Chairman of the Hong Kong Branchof the United Kingdom Institute of Healthcare Engineering and EstateManagement (IHEEM), expressed his heartfelt gratitude to the engineeringsector for their unwavering support. Working as one, in 2020, , the industry adopted the advanced “Modular Integrated Construction” (MiC) technology,coupled withthe “Multi-trade Integrated Mechanical, Electrical, and Plumbing” (MiMEP)construction method, to construct the world’s first high-standard negative-pressure isolation ward module that could be assembled and deployed superfast, marking a groundbreaking achievement of Hong Kong’s engineering sector.The design of the high-standard negative-pressure isolation ward featuresa self-sufficient airflow system enabled by the MiMEP construction method,that does not require a centralised air-conducting system withextensive external ventilation ducts. The built-in ventilation and air-conditioning system can effectively control infection by creating the necessary airflow path in the ward. Picture shows Prof Yuen conducting a smoke test showing air only flowing in one direction into the ward or being extracted through the ventilation system.Rigorous ventilation tests verified that the high-standard negative-pressureisolation ward can provide a high-quality negative-pressure environment,effectively blocking the transmission of highly infectious airborne particles to outside occupying areas.After the pandemic, the high-standard negative-pressure isolation ward module was put on an about two-year public display at the CIC-Zero CarbonPark in Kowloon Bay to promote the “Modular Integrated Construction” (MiC)method. When the display ends in 2025, some components of the module willbe recycled for purposes including reuse and further research.In addition to the double interlocking door control systems installed at the entrances to regulate airflow, the high-standard negative-pressure isolation ward is equipped with ultraviolet (UV) disinfection dual-door pass-through boxes to give patients convenience access to external supplieswhile minimising the need for medical staff to enter and exit the ward, assuch reduce viral transmission risks.The design of the ward eliminates the need for extensive external ventilation ducts or a centralised air-conditioning system. Instead, it utilises the self-sufficient ventilation and air-conditioning system coming with the MiMEP construction method that ensures a controlled only-into-the-ward airflow to effective prevent infection transmission.The design of the ward eliminates the need for extensive external ventilation ducts or a centralised air-conditioning system. Instead, it utilises the self-sufficient ventilation and air-conditioning system coming with the MiMEP construction method that ensures a controlled only-into-the-ward airflow to effectively prevent infection transmission.About Ir Prof P L YUENIr Prof P L YUEN is a professional engineer of 40 years in the healthcare engineering sector in Hong Kong. Early in his career, he worked in government departments, where he was responsible for construction, operation and maintenance of hospitals. Currently, he oversees the design and management of hospital engineering facilities within public healthcare institutions. Additionally, he leads the environmental and energy sustainability initiatives of both existing and planned hospitals, as well as hospital expansion projects across Hong Kong.On combating the COVID 19 pandemic, armed with years of experience in research, design and construction of hospital ventilation system facilities, he was able to timely innovate and turn hospital wards into negative-pressure wards, including the community treatment facility at AsiaWorld-Expo, to meet the urgent need for public medical isolation facilities. During the epidemic, he was Government appointed Chairman of the Working Group on Implementing the Requirement on Air Change or Air in Dine-in Purifiers Restaurants that helped more than 18,000 eateries in Hong Kong improve ventilation in a few months, contributing to pandemic control in the community. Early in his career, he was invited by WHO and UNOPS to be their expert advisor and had travelled several times to Indonesia to offer technical guidance on how to build isolation wards across public hospitals there.Ir Prof YUEN is the past President of the Hong Kong Institution of Engineers (HKIE), the current Chairman of the Engineers Registration Board in Hong Kong, the Hong Kong Branch Chairman of the United Kingdom Institute of Healthcare Engineering and Estate Management (IHEEM) and the past Vice President of the United Kingdom Chartered Institution of Building Services Engineers (CIBSE). In 2023, he was re-elected as Deputy Chair of the International Engineering Technologists Agreements (IETA) and was elected as Chair of the Seoul Accord. He is also a member of the Executive Committee of the International Engineering Alliance (IEA). An active participant in the work of international professional organisations and platforms, he has contributed much to consolidating the professional standard and promoting mobility of the engineering sector. He was bestowed Fellowship by the Energy Institute (EI) UK and received the Lifetime Achievement Award from IHEEM UK, and recently the Gold Medal, the highest honour, from UK CIBSE. He has been a Council member of the China Hospital Association's Architectural Research Branch for close to two decades. In 2020, for his outstanding contribution to the fight against COVID-19, Ir Prof YUEN was presented the “Chief Executive’s Commendation for Community Service” by the Hong Kong SAR Government. Copyright 2024 ACN Newswire via SeaPRwire.com.

香港, 2024年12月30日 - (亚太商讯 via SeaPRwire.com) - 专营藻油DHA、益生菌、维生素、多维营养素及藻钙产品的中国领先母婴营养制成品营销、销售及分销商纽曼思健康食品控股有限公司（"纽曼思"或"集团"），今日公布在香港联合交易所有限公司（"香港联交所"）主板上市计划的详情。集团拟发售合共250,000,000股股份，其中225,000,000股股份作国际发售（可予重新分配），25,000,000股股份作香港发售（可予重新分配）。指示性发售价范围介乎每股发售股份0.80港元至1.09港元。假设发售价为每股发售股份0.95港元（即指示性发售价范围的中位数）及超额配股权未获行使，经扣除就全球发售应付的包销费及相关上市开支后后，预计全球发售所得款项净额约为156.3百万港元。香港公开发售将于2024年12月30日（星期一）开始，并于2025年1月7日（星期二）正午结束。股份预期将于2025年1月10日（星期五）于香港联交所主板挂牌买卖，股份代号为2530，每手买卖单位为8,000股股份。财通国际融资有限公司的独家保荐人及独家整体协调人。财通国际证券有限公司及富华建业证券有限公司为联席全球协调人、联席账簿管理人及联席牵头经办人。中国光大证券（香港）有限公司、First Fidelity Capital (International) Limited、富途证券国际（香港）有限公司、辉立证券（香港）有限公司、东吴证券国际经纪有限公司及众宸证券有限公司为联席账簿管理人及联席牵头经办人。投资亮点扎根母婴营养品行业多年，拥稳健的市场定位及高度品牌认可纽曼思早于2007年进军中国母婴营养品市场，为中国母婴营养品行业藻油DHA分部的专属品牌拥有人。集团以专属品牌"纽曼思"及"纽曼斯"（Nemans）营销营养品，满足孕妇及产后妇女、婴儿以至儿童不同阶段的营养需求。集团凭借在行业的悠久历史及良好声誉、产品质量优良加上完善且多元化的销售及分销网络，使集团从竞争对手中脱颖而出，并持续保持竞争优势，从而把握市场上不断涌现的机遇。纽曼思之业务稳步上升，收益由2021财政年度的约人民币337.6百万元增加至2023财政年度的约人民币426.5百万元；毛利率于2021至2023财政年度、以及2023及2024年6个月，维持稳定于70%以上。经调整纯利[1]由2021财政年度的约人民币130.4百万元增加至2023财政年度的约人民币172.3百万元，升幅达32%。根据弗若斯特沙利文咨询报告，集团在2023财政年度于中国藻油DHA市场的零售销售值，无论是与中国市场国际及国内藻油DHA品牌相比，还是仅与国内藻油DHA品牌比较，均位居首位。凭借藻油DHA产品的成功，集团持续推广其专属品牌下的其他营养品（如益生菌、维生素、多维营养素及藻钙产品），以满足消费者的不同需求和消费偏好。多年来，集团荣获包括2021天猫双11全球狂欢节的"增长引擎奖"、"2022年度天猫婴童食品行业奖 - 年度超级单品奖 - 年度宝宝营养品"及"2023财年天猫国际品类冠军营"在内的各种奖项，彰显其营养品深受市场认可。多元销售渠道，扩大市场渗透纽曼思在中国拥有多元化且覆盖线上及线下渠道的销售及分销网络。集团的线上销售渠道包括在中国流行的网购平台，而鉴于近年来电子商务日益普及加上消费者对网上资讯的依赖，集团亦会透过线上销售渠道提供资讯及宣传其营养品与品牌。于2021财政年度、2022财政年度、2023财政年度及2024年6个月，线上销售渠道的收益占相应年度╱期间的收益分别64.1%、66.3%、73.0%及80.7%。于往绩期间，集团有绝大部分的收益来自网购平台，包括淘宝、抖音及京东。线下销售渠道方面，于2024年6月30日，集团委聘了17名地区分销商于中国各地销售及分销产品。集团的产品借助该等地区分销商的下游销售渠道，如药房、母婴产品店、产后护理中心、零售店及其次级分销商，渗透入中国各地的市场。集团亦定期对各分销商进行管理、监察并培训，确保他们熟知集团的营养品。该等线下销售渠道布局，令集团的产品得以覆盖中国多地，并加速进入中国各主要城市的步伐。集团相信，其在中国的多元化销售及分销网络赋予集团坚实的基础，以利于进一步扩大产品销售，并提高产品及品牌的市场认可度。同时，该等多元化的销售及分销网络亦有助集团降低在任何当地市场的集中风险。策略性地选择主要原材料海外供应商，提升市场信心纽曼思相信，维持营养品所用原材料的质量及安全是成功的关键。因此，集团透过策略性地选择营养品的主要原材料海外供应商，维护及保持产品质量。具体而言，集团严格要求藻油DHA成品供应商使用全球藻油DHA市场的领导者帝斯曼集团[2]供应的主要原材料，及要求所有益生菌产品的供应商使用益生菌原材料供应商[3]供应的原材料。根据弗若斯特沙利文咨询报告，使用国际一流原材料的产品备受中国母婴营养品行业的消费者欢迎。因此，集团这一策略有助保证其产品质量、提升消费者信心，从而维护及提高集团的声誉。集团对产品品质的坚持亦备受行业肯定。集团荣获由宝宝树（中国孕产妇及婴儿社区平台）颁发的"Babytree宝宝树金树奖 - 2020年度优质国民品牌奖"，由CBME孕婴童展颁发的"CBME 2020感恩同行共生未来 - 荣耀品牌伙伴奖"及由育儿网（一家中国育儿网站）颁发的"2021年度育儿网橙品清单妈妈口碑之选 - 宝宝用品年度人气营养品"。集团亦于2019年至2021年连续三年获得由母婴行业观察及樱桃大赏评委会颁发的"樱桃大赏 - 年度婴幼儿营养品品牌最佳表现力大奖"及于2022年获得"第八届樱桃大赏 - 年度婴幼儿营养品品牌杰出表现力大奖"；并于2023年，再次荣获"天猫国际母婴行业紫曜雷霆奖"。管理团队经验丰富，确保业务可持续发展纽曼思由一支经验丰富及尽忠职守的管理团队带领，团队具备有关中国营养品市场的丰富经验及渊博知识。集团的主席、行政总裁及执行董事王平先生于企业营运及管理方面拥有超过20年经验，自集团成立以来一直管理本集团。而负责集团整体营运及管理的安勇先生，曾任澳美澳乳业总经理，拥有超过17年的食品行业。同时，集团的其他高级管理层成员于营养品行业拥有多年经验或具备相关的管理和财务专长，令集团得以制定及实施适当的业务策略，快速应对中国营养品市场瞬息万变的市场环境及需求，有助集团实现可持续增长。业务策略纽曼思的业务目标是实现可持续增长、提高市场份额及巩固集团在中国营养品市场的市场地位。为进一步实现该等目标，集团计划采取以下策略：透过多种方法增加营销投入，提升集团品牌知名度纽曼思相信，成功的品牌建设是业务发展的关键。集团已经将"纽曼思"及"纽曼斯"（英文名称为"Nemans"）发展为在中国获高度认可的品牌。自2007年首次对出DHA产品以来，集团的营销、销售及分销主要集中于中国的一线、新一线及二线城市，但广东省、江苏省、山东省、浙江省及安徽省的若干三、四线城市（如汕头、江门、揭阳、湛江、肇庆、潮州、清远等）（"选定城市"）的营养品行业亦存在巨大潜力和机遇。根据弗若斯特沙利文咨询报告，选定城市的营养品市场总规模2018至2023年复合年增长率约为28.6%，预期至2028年复合年增长率将达19.9%；其年度人均可支配收入约为人民币25,000元至人民币68,000元，与该等省份的一、二线城市有或多或少的重迭区间；由于业内领先品牌历来集中在中国的一线、新一线及二线城市进行营销及销售，选定城市的市场竞争亦较小。有见及此，为进一步推广产品、提升品牌知名度及形象，并加强尤其是对现有销售及分销网络尚未覆盖或覆盖不足的较低发展地区的渗透力，集团拟透过不同的方式加强市场营销工作，进一步扩大销售及分销网络，提高线上及线下渠道的销售额。对于线上渠道，集团将在社交媒体平台及网购平台进行网上营销以及推广其品牌及产品。而针对线下渠道，集团将扩大线下销售网络、举办及参与会议、大型贸易展览会及业界活动。集团已计划于未来三年各年底前举办约15至20场会议。在香港推广集团的产品，并将销售网络扩展到当地根据弗若斯特沙利文咨询报告，鉴于在中国母婴营养品行业，使用进口原材料的产品颇受客户青睐，国内品牌在香港开设办事处和商店，应可进一步加强其进口原材料和海外加工的产品在客户心中的形象及印象，而在香港销售的营养品亦被中国消费者认为更值得信赖和可靠。因此，集团计划透过在香港推广其产品，并将销售网络延伸至当地，进一步加强其品牌形象。为此，集团拟在香港中环一个购物中心设立一家零售店；加之其藻油DHA及益生菌产品使用国际供应商提供的主要原材料，集团相信，有关策略可进一步加强集团品牌的国际元素。同时，集团计划聘请设于香港的独立营销代理，在香港为集团的产品开展一系列的促销活动。有关营销及推广服务将包括：电视广告、户外平面广告、开幕活动管理、赞助管理、数字平台策略性推广，及在婴童展和其他巡回展览中进行推广。集团亦拟于香港设立一个办事处及仓库，以支持集团当地零售店运作及产品分销。所得款项用途项目约向着名且受欢迎的KOL购买营销及推广服务34.5%购买电商公司的品牌营销及推广产品22.0%参与会议及大型贸易展览会及业界活动7.0%在香港中环一座购物中心设立零售店12.6%聘请香港的独立营销代理18.0%在香港设立办事处及仓库5.9%关于纽曼思健康食品控股有限公司纽曼思健康食品控股有限公司是一家专注于高品质藻油DHA、益生菌、维生素、多维营养素及藻钙产品的中国领先营养制成品营销、销售及分销商。作为中国母婴营养品行业藻油DHA分部的专利品牌拥有人，集团旗下两大核心品牌"纽曼思"及"纽曼斯"（Nemans），透过多元化的销售及分销网络，为中国消费者提供优质的健康及营养解决方案。根据弗若斯特沙利文咨询报告，集团在2023财政年度于中国藻油DHA市场的零售销售值，无论是与中国市场国际及国内藻油DHA品牌相比，还是仅与国内藻油DHA品牌比较，均位居首位。此外，在使用海外供应商供应的藻油DHA原材料的中国前五大母婴藻油DHA国内品牌中（总计市占率达62.3%），集团的零售销售值高居榜首。如欲了解更多，请访问集团官方网站：https://www.numans.cc/[1] 经调整纯利（非香港财务报告准则计量）的定义为加回上市开支的经调整年╱期内纯利。[2] 根据弗若斯特沙利文咨询报告，帝斯曼集团被视为中国藻油DHA市场的领导者，按产量及价值计算，于2023年制造中国藻油DHA市场超过40%的原材料及成品。[3] 根据弗若斯特沙利文咨询报告，该供货商于2023年为中国最大益生菌原材料供货商之一，占当年中国益生菌原材料供应市场总收益约35% Copyright 2024 亚太商讯 via SeaPRwire.com.

香港, 2024年12月30日 - (亚太商讯 via SeaPRwire.com) - 香港医疗工程业界一直积极响应香港特别行政区政府推动先进科技建筑法，以实现高效建筑。业界于2020年采用先进的"组装合成"（MiC）建造技术，配以"机电装备合成法"（MiMEP），成功建造全球首个组装合成可快速建造的高规格负压隔离病房的模组。该模组早在2020年第一波疫情开始被征用作抗疫用途。疫后负压隔离病房的模组被转送到九龙湾建造业零碳天地作为期约两年的公众展览，以推广组装合成建筑法。模组于2025年完成公众展览后，部分组件将会被回收，作进一步研究等用途。此项目展现了创新工程技术在用于公共卫生方面的巨大潜力，并为模组化设计传染病隔离设施的技术奠定了坚实的基础。香港工程业界过去一直群策群力，运用崭新思维和技术，为对抗新冠疫情出一分力。由设计草图到落成项目，业界仅用了四个月的时间，于2020年5月成功打造出媲美医院规格的负压隔离病房，并成为全球首例，及后此设计方案更被誉为"港版火神山"。此设施设计展现了香港工程界的专业能力、创新精神以及在危机时刻的快速应变能力，更为全球应对这类事件提供了重要的参考范例。该项目采用先进的MiC建造技术，配以MiMEP两种高效建筑方法相辅相成，共同提高建筑效率，让整个建造周期仅需约一个月的时间。MiC技术允许近八成的工序在工厂预制完成，再运送至现场快速组装和调试，显著缩短了在工地的建造时间，并确保了工程质量和可持续性。经严格的通风测试验证，这些病房能提供高效的负压隔离环境，有效阻断高传染性病毒粒子经空气的传播。隔离病房设计的特点是不需外置大量风喉等的中央空调系统支援，以 MiMEP 内藏的通风空调自给自足形成所需的空气流向设计，得以有效控制感染。因应香港寸金尺土的情况，须设计出能在狭小空间建成的项目，这个"高度浓缩设计"在当时来说是全球首例。香港工程师学会前会长、英国屋宇装备工程师学会前副会长、英国医疗工程学会香港分会主席源柏樑教授、工程师表示："当年受到国家'火神山'项目的启发，开始构思如何在有限的空间内建成高规格的隔离病房，要有双门连锁控制，以达至精准控制气流走向，为了便于运输，因此以标准货柜箱体积为蓝本而设计，是其中一个理想的选项。结合MiC和MiMEP两种建筑方法，可实现病房自给自足的通风空调设计，以及透过较小的机电模组连接每间病房供电，这项创新设计亦成为当时的全球首例。"源教授在其时亦分享了这设计给各工程同业，合作建设更多合适的隔离设施。源教授补充："组装合成高规格负压隔离病房的成功，证明了工程创新在应对公共卫生挑战中的重要作用。该项目已完成其历史任务，但这并非终点，我期望透过这次成功的经验，更好地响应政府以此新颖的高效建筑方法，建造更多先进的建筑项目，并鼓励香港更多工程师投身创科创新行列，携手演译及说好香港工程故事。"香港工程师学会前会长、英国屋宇装备工程师学会前副会长、英国医疗工程学会香港分会主席源柏樑教授、工程师衷心感谢工程业界的鼎力支持，群策群力于2020年采用先进的"组装合成"（MiC）建造技术，配以"机电装备合成法"（MiMEP），成功建造全球首个组装合成可快速建造的高规格负压隔离病房的模组，成就香港工程界的创举。此组装合成高规格负压隔离病房的设计特点是不需外置大量风喉等的中央空调系统支持，以"机电装备合成法"（MiMEP）内藏的通风空调自给自足形成所需的空气流向设计，得以有效控制感染。图标香港工程师学会前会长、英国屋宇装备工程师学会前副会长、英国医疗工程学会香港分会主席源柏樑教授、工程师进行烟雾测试，显示空气只会单向流入病房，或经通风系统被抽走。经严格的通风测试验证，此组装合成高规格负压隔离病房能提供高质量的负压隔离环境，有效阻断高传染性粒子经空气的传播。疫后高规格负压隔离病房的模组被转送到九龙湾建造业零碳天地作为期约两年的公众展览，以推广组装合成建筑法。模组于2025年完成公众展览后，部分组件将会被回收，作进一步研究等用途。此组装合成高规格负压隔离病房除了在出入口安装双重门控制气流之外，亦设有紫外光消毒双重门传递箱，方便病人随时接收房外物资的同时，尽量减少医护人员进出病房的次数，降低病毒传播的风险。此组装合成高规格负压隔离病房的设计特点是不需外置大量风喉等的中央空调系统支持，以"机电装备合成法"（MiMEP）内藏的通风空调自给自足形成所需的空气流向设计，即空气只会流入病房，不会从病房流出，得以有效控制感染。此组装合成高规格负压隔离病房的设计特点是不需外置大量风喉等的中央空调系统支持，以"机电装备合成法"（MiMEP）内藏的通风空调自给自足形成所需的空气流向设计，即空气只会流入病房，不会从病房流出，得以有效控制感染。关于源柏樑教授、工程师源柏樑教授、工程师是一位专业工程师，他为香港医疗工程界服务四十年。早年在香港政府部门任职期间，源教授、工程师开始参与医院的建造、营运和维护。目前，他在公营医疗机构负责监督医院的工程设施设计及管理。他亦带领环境及能源可持续发展方面的工作，涵盖本港现有医院、新建及扩建医院项目。在对抗新冠肺炎疫情方面，他凭借多年有关研究及设计和建设医院通风系统设施的经验，适时创新设计及改建医院内病房为负压病房包括亚博馆小区治疗设施，以应付公共医疗对隔离设施的急切需求。抗疫其间源教授更担当政府"食肆换气量规定工作小组"主席，在短短几个月内为逾 18,000 家食肆改善通风，为小区的疫情防控带来莫大裨益。他早年亦受世界卫生组织及联合国项目事务邀请担任专家顾问，数度到印度尼西亚为当地公立医院建造隔离病房给予工程技术指导。源教授、工程师为"香港工程师学会"前任会长，现任香港"工程师注册管理局"主席，"英国医疗工程学会"香港分会主席，以及"英国屋宇装备工程师学会"前任副会长。源教授、工程师于二零二三年再度获选为"国际工程技术士协议"副主席，并同时当选出任"首尔协议"主席，亦成为"国际工程联盟"执委会成员。源教授、工程师积极参与全球各个国际工程专业组织及平台工作，为巩固工程专业水平及推动工程界有更广泛流动性作出不少贡献，获"英国能源学会"颁授荣誉院士、及"英国医疗工程学会"终身成就奬，最近更获得"英国屋宇装备工程师学会"授予学会最高荣誉的金奬奬章，他亦已作为委员服务了"中国医院协会"医院建设分会接近二十年。在二零二零年，源教授获香港特别行政区颁授"行政长官社会服务奖状"，以表彰他于对抗新冠疫情所作出的杰出贡献。 Copyright 2024 亚太商讯 via SeaPRwire.com.

Boca Raton, Florida--(ACN Newswire via SeaPRwire.com - December 30, 2024) - Atlas Lithium Corporation (NASDAQ: ATLX) ("Atlas Lithium" or "Company"), a leading lithium pre-production company, is pleased to announce two pivotal additions to its leadership team, marking a significant step forward in the Company's journey to becoming a leading lithium producer at its Neves Project in Brazil's thriving Lithium Valley.Strengthening Project Implementation Expertise with Eduardo QueirozEduardo Queiroz joins Atlas Lithium as Project Management Officer (PMO) and Vice President of Engineering, bringing over 20 years of hands-on experience managing complex, large-scale mining projects, and making him the perfect addition to drive the Company's Neves Project to revenue generation. Mr. Queiroz has more than two decades of expertise in managing large-scale and complex mining projects, most recently as General Manager of Planning and Management at Bamin, a unit of Eurasian Resources Group, where he successfully led the strategic planning of several projects over US$3 billion, including an integrated iron ore mining project encompassing mining operations, processing plant, railway, and ocean port facilities. His comprehensive experience includes engineering oversight, environmental compliance, risk management, and the implementation of cost-efficient operational strategies. He holds an MBA in Project Management from Fundação Getúlio Vargas and a degree in Civil Engineering from the Universidade Federal de Ouro Preto."Eduardo's arrival could not come at a better time," said Marc Fogassa, CEO and Chairman of Atlas Lithium. "As we prepare to transition into production, his proven track record in the implementation of Brazilian mining projects will be instrumental in our success. We are honored and thrilled to have him on our team."Expanding Asian Market Presence with Lili WuIn addition to strengthening our technical capabilities, Atlas Lithium is expanding its global footprint with the appointment of Lili Wu as Head of Business Development for Asia. Based in Beijing, Ms. Wu brings a wealth of knowledge and an extensive network in the lithium and battery materials industries. Her prior roles at InsightWoo and IHS Markit (now part of S&P Global) demonstrate her ability to drive results in international markets. From negotiating long-term procurement agreements to advising top financial institutions on lithium investments, she has a proven ability to add value in the ever-evolving lithium supply chain. Ms. Wu holds a Master's degree in Accounting from the University of New South Wales and a Bachelor's degree in International Trade from Beijing International Studies University.The appointment of Ms. Wu comes at a strategic time as Atlas Lithium continues to strengthen its market presence in regions experiencing robust electric vehicle growth. Recent market data shows China's electric vehicle (EV) sales jumped 51% year-over-year as of November 2024, underlining the region's vital role in the global energy transition. With established offtake agreements with major partners like Mitsui & Co. in Japan and leading lithium chemical producers Chengxin and Yahua in China, Atlas Lithium has commercial relationships in key growth markets. This global approach positions the Company to capitalize on worldwide opportunities in the lithium supply chain while reducing dependence on any single regional market."I have had the privilege of working with Lili and her contributions have already been invaluable to Atlas Lithium," said Fogassa. "Her unparalleled work ethic and deep understanding of the Asian lithium market make her the perfect ambassador for this high EV growth region."Positioned for Global SuccessThese strategic hires reflect the Company's unwavering commitment to excellence as it advances toward production. Eduardo Queiroz and Lili Wu represent the next generation of leadership at Atlas Lithium, bringing the vision, expertise, and energy we need to achieve our ambitious goals."At Atlas Lithium, our mission is not just to mine lithium but to power the world's transition to sustainable energy," said Fogassa. "With Eduardo's operational expertise and Lili's unmatched ability to navigate the dynamic Asian markets, we are well-positioned for growth. With a world-class team and a clear vision, Atlas Lithium is ready to deliver value to our shareholders, partners, and the global energy ecosystem."About Atlas Lithium Corporation Atlas Lithium Corporation (NASDAQ: ATLX) is advancing to production its wholly owned hard-rock lithium Neves Project located in the state of Minas Gerais, Brazil. The Neves Project has received operational permitting from Minas Gerais in October 2024. Additionally, with 539 square kilometers of lithium mineral rights, Atlas Lithium owns the largest lithium exploration footprint in Brazil of any publicly listed company. The company also holds a 32.7% ownership stake in Atlas Critical Minerals Corporation (formerly Jupiter Gold Corporation), a diversified mining company with significant mineral rights in rare earths, copper, graphite, nickel, iron ore, gold, and quartzite.Safe Harbor StatementThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward looking statements are based upon the current plans, estimates and projections of Atlas Lithium and its subsidiaries and are subject to inherent risks and uncertainties which could cause actual results to differ from the forward-looking statements. Such statements include, among others, those concerning market and industry segment growth and demand and acceptance of new and existing products; any projections of production, reserves, sales, earnings, revenue, margins or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements regarding future economic conditions or performance; uncertainties related to conducting business in Brazil, as well as all assumptions, expectations, predictions, intentions or beliefs about future events. Therefore, you should not place undue reliance on these forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: results from ongoing geotechnical analysis of projects; business conditions in Brazil; general economic conditions, geopolitical events, and regulatory changes; availability of capital; Atlas Lithium's ability to maintain its competitive position; manipulative attempts by short sellers to drive down our stock price; and dependence on key management.Additional risks related to the Company and its subsidiaries are more fully discussed in the section entitled "Risk Factors" in the Company's Form 10-K/A filed with the Securities and Exchange Commission (the "SEC") on November 9, 2024. Please also refer to the Company's other filings with the SEC, all of which are available at www.sec.gov. In addition, any forward-looking statements represent the Company's views only as of today and should not be relied upon as representing its views as of any subsequent date. The Company explicitly disclaims any obligation to update any forward-looking statements.Investor RelationsGary GuytonVice President, Investor Relations+1 (833) 661-7900gary.guyton@atlas-lithium.comhttps://www.atlas-lithium.com/@Atlas_LithiumTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/235457 Copyright 2024 ACN Newswire via SeaPRwire.com.